CCL2 and COVID-19: Like SPP1, CXCL10, and CCL2, whose plasma levels associate with COVID-19 severity (63, 65–71, 74, 75), the plasma level of CCL18 was also found to be significantly different between patients with mild and critical COVID-19 (Figure 6C).